Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies-Reference-Cited by-同舟云学术

Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies

Published:2010-03 Issue:5 Volume:18 Page:1875-1881
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Karuppasamy Muthukumar,Mahapatra Manojkumar,Yabanoglu Samiye,Ucar Gulberk,Sinha Barij Nayan,Basu Arijit,Mishra Nibha,Sharon Ashoke,Kulandaivelu Umasankar,Jayaprakash Venkatesan

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference39 articles.

1. The therapeutic potential of monoamine oxidase inhibitors

2. Oxidase Inhibitors In Developments of Drugs and Modern Medicines,1986

3. Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism

4. Some observations upon a new inhibitor of monoamine oxidase in brain tissue

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diverse Pharmacological Potential of different Substituted Pyrazole Derivatives;Current Organic Synthesis;2023-10-12

2. Possible Mechanisms for the Prevention of Anxiety and Depressive-Like Behavior in a Chronic Mild Stress Mouse Model by the Thai Herbal Medicine with Nelumbo nucifera, Centella asiatica, and Piper nigrum;Revista Brasileira de Farmacognosia;2023-05-13

3. Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies;European Journal of Medicinal Chemistry;2022-11

4. Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders;ACS Omega;2022-10-17

5. Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer;Molecules;2022-04-30